Tarsus Pharmaceuticals, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Irvine, CA
TARS chart
What traders are saying about $TARS
Latest postsTarsus Pharmaceuticals, Inc. news
- Will Wider Q3 Loss Change Tarsus Pharmaceuticals Stock Narrative
Simply Wall St ·
- Tarsus Pharmaceuticals, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:TARS) 2026-11-07
Seeking Alpha ·
- What Is Drawing Fresh Attention To Tarsus Pharmaceuticals (TARS)?
Simply Wall St ·
- Is Raised Revenue Outlook Altering The Investment Case For Tarsus Pharmaceuticals (TARS)?
Yahoo Finance ·
- Is Tarsus Pharmaceuticals (TARS) Below Fair Value On Cash Flow?
Yahoo Finance ·
- Tarsus Pharmaceuticals (TARS) Stock May Trade At A Discount On Strong Sales Growth
Simply Wall St ·
- Tarsus Pharmaceuticals : Initial Statement of Beneficial Ownership (Form 3)
www.marketscreener.com ·
- Tarsus Pharmaceuticals (TARS) Could Be 31% Undervalued Following Record Q3 Sales
Yahoo Finance ·
- Tarsus Pharmaceuticals to present at three majo...
Pluang ·
- Tarsus to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Tarsus plans two investor talks, in November and December
Stock Titan ·
- HRMY Q3 Earnings Miss Estimates on Higher Costs Despite Wakix Growth
Yahoo Finance ·
Tarsus Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $451.4M | $183.0M | $17.4M | $25.8M |
| Net income | -$66.0M | -$116.0M | -$136.0M | -$62.1M |
| Diluted EPS | $-1.59 | $-3.07 | $-4.62 | $-2.52 |
| Total assets (year end) | $562.2M | $377.0M | $265.5M | $227.9M |
| Cash and equivalents (year end) | $183.6M | $94.8M | $224.9M | $71.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Tarsus Pharmaceuticals, Inc.
- Ticker
- TARS (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Irvine, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1819790
Frequently asked questions
What exchange is Tarsus Pharmaceuticals, Inc. listed on?
Tarsus Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol TARS.
What industry is Tarsus Pharmaceuticals, Inc. in?
Tarsus Pharmaceuticals, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Tarsus Pharmaceuticals, Inc. headquartered?
Tarsus Pharmaceuticals, Inc.'s business address on file with the SEC is in Irvine, CA.
When does Tarsus Pharmaceuticals, Inc.'s fiscal year end?
Tarsus Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Tarsus Pharmaceuticals, Inc. report?
Tarsus Pharmaceuticals, Inc. reported $451.4M in revenue for calendar year 2025, according to its SEC filings.